{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hiv-infection-aids/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"2ebcd00e-1208-5405-bf59-2bcb374d5cbf","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field aeb02627-bc6c-4beb-b7d1-65c5a9c87986 --><h2>How common is it?</h2><!-- end field aeb02627-bc6c-4beb-b7d1-65c5a9c87986 -->","summary":"","htmlStringContent":"<!-- begin item dbee36f6-d6e2-4a2d-8cbb-963771fbd73e --><!-- begin field b180bef5-cd31-4dda-a40c-aa0164e9e4b4 --><h3>Globally</h3><ul><li>At the end of 2018, 37.9 million people were living with HIV worldwide [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">WHO, 2019</a>].<ul><li>The prevalence of HIV varies widely between regions — the World Health Organization (WHO) African region is most severely affected with 25.7 million people (more than two-thirds of all people living with HIV globally) infected.</li></ul></li><li>In 2018, 770,000 people died of HIV-related illness and 1.7 million people were newly infected [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">WHO, 2019</a>].</li><li>Between 2000 and 2018, new HIV infections fell by 37% and owing to more widespread use of anti-retroviral therapy HIV-related deaths fell by 45% [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">WHO, 2019</a>].</li></ul><h3>UK</h3><ul><li>At the end of 2018, an estimated 103,800 people were living with HIV in the UK with 7500 unaware of infection. Of these approximately [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">PHE, 2019a</a>]:<ul><li>49,800 were gay or bisexual men.</li><li>48,600 were heterosexual (19,000 men and 29,600 women).</li><li>2300 were people who inject drugs.</li></ul></li><li>New diagnoses of HIV peaked in 2014 (at 6278) and have declined since then (to 4453 in 2018) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">PHE, 2019b</a>].<ul><li>The decline is most marked among gay, bisexual, and other men who have sex with men where diagnoses fell by 35% (from 3480 in 2014 to 2250 in 2018).</li><li>The number of new HIV diagnoses in people who acquired HIV heterosexually has almost halved over the last decade from 3400 in 2009 to 1940 in 2018.</li><li>Nearly half of all adults diagnosed in 2018 who acquired HIV heterosexually were born in a country of high HIV prevalence.</li></ul></li><li>In 2018, 473 people with HIV infection died from all causes in the UK (median age of death 55 years) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">PHE, 2019b</a>].</li><li>The number of HIV infections acquired through injecting drug use and mother-to-child vertical transmission in the UK is low.<ul><li>In 2018, 94 new HIV diagnoses were acquired through injecting drug use [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">PHE, 2019b</a>].</li><li>The success of the antenatal HIV screening programme for pregnant women has meant that mother-to-child transmission of HIV in the UK has almost been eliminated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">PHE, 2019c</a>].</li></ul></li><li>The number of people diagnosed with an AIDS-defining illness at HIV diagnosis has more than halved over the past decade (from 500 in 2009 to 225 in 2018) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hiv-infection-aids/references/\">PHE, 2019b</a>].<ul><li>In 2018, where illness data were reported, pneumocystis pneumonia remained the most commonly diagnosed AIDS-defining illness (37% of AIDS diagnoses), followed by candidiasis (22%), tuberculosis (8%), and Kaposi’s sarcoma (8%).</li></ul></li></ul><!-- end field b180bef5-cd31-4dda-a40c-aa0164e9e4b4 --><!-- end item dbee36f6-d6e2-4a2d-8cbb-963771fbd73e -->","topic":{"id":"6c2470d2-9bde-5a16-91a3-b5ed74ce2d2b","topicId":"23723770-8df0-4d05-aa4f-806db67f71df","topicName":"HIV infection and AIDS","slug":"hiv-infection-aids","lastRevised":"Last revised in July 2020","chapters":[{"id":"a83635cf-fad1-569e-8fec-1e53dd8ae096","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"21903de2-55a7-5de1-8f40-7d516cf2a7ba","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"34d5dabb-0626-5dfe-9e0a-07e7dac0ec58","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"996367e5-1657-59c5-9c56-45a1e1013995","slug":"changes","fullItemName":"Changes"},{"id":"e5a3550d-1cdf-573d-b498-dc61010e00ab","slug":"update","fullItemName":"Update"}]},{"id":"e6ed5291-d099-5df0-8884-8a42f12be67c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"da045857-e127-5b13-806b-efd61a584eed","slug":"goals","fullItemName":"Goals"},{"id":"f469da13-a03c-5ee1-94e5-b8eafe0a4710","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c9fb3313-7788-5815-b332-9c471eca306c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"63177a9d-218c-57dc-b3b2-7ed72c934d64","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cee63c61-94d3-58f8-baf1-490fff9ea45c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c8f3f309-15a8-577b-a923-a9df302e83dc","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5280ae8d-7f20-59e3-9659-6d5e8ee732d9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"77dcc0b6-d3f2-5853-af16-2b7fe5c92758","slug":"definitions","fullItemName":"Definitions"},{"id":"2ebcd00e-1208-5405-bf59-2bcb374d5cbf","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9568c950-bbaa-5f5f-aec3-01eb3d3f1cad","slug":"transmission-of-hiv-infection","fullItemName":"Transmission of HIV infection"},{"id":"d63a1c6b-b5d0-585d-b2bd-32d7585a1348","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"a37da596-8c70-54d6-a7c0-b3ff5e433932","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a8377091-e41a-5f81-ac03-60a09edc5331","slug":"complications","fullItemName":"Complications"}]},{"id":"86f39b6e-86fd-5704-81c5-1d7bc804e489","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6937cde7-2e91-5c9f-943e-a3772fdf8fff","slug":"symptomatic-hiv-infection","fullItemName":"Symptomatic HIV infection"},{"id":"bb429eff-4661-5c71-bccb-6c98e9738ee7","slug":"asymptomatic-hiv-infection","fullItemName":"Asymptomatic HIV infection"}]},{"id":"34037594-c7af-59e7-b51e-d4252ee167e2","fullItemName":"Management","slug":"management","subChapters":[{"id":"52deca6b-97b2-52f6-8f9b-734f8717e443","slug":"new-hiv-diagnosis","fullItemName":"Scenario: New HIV diagnosis"},{"id":"10c2085e-ef4b-579a-994f-267109c1bfb5","slug":"acute-hiv-related-problems","fullItemName":"Scenario: Acute HIV-related problems"},{"id":"4c89980b-d988-5bb0-97eb-85427710fb28","slug":"established-hiv-infection","fullItemName":"Scenario: Established HIV infection"},{"id":"fbe0aece-9feb-59c8-8a0e-b822d115f38c","slug":"post-exposure-prophylaxis","fullItemName":"Scenario: Post-exposure prophylaxis"}]},{"id":"5e2f04ec-05b3-5cf1-a129-77b19bc1c3fb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"b7b51785-6622-5495-ab3a-eaf744121195","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0d080358-7d15-5c10-9583-e229d17ecc83","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e3da2b1c-f5c2-51bc-a4af-783d017c48ed","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"275bacfc-149b-5bad-aeb5-3b04ee60f812","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e73775d9-24cb-5d49-86c5-7394e52ada27","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e580fed6-5846-5aef-9890-4b21946b4ffb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"72914ee0-80fc-59a4-8670-236701fce130","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5280ae8d-7f20-59e3-9659-6d5e8ee732d9","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}